Adding further evidence to the significance for depression, NEGR1 levels in the CSF of patients affected by major depression or bipolar disorder were significantly higher than in controls; this biomarker provided a major contribution to the identification of a biosignature, allowing for the correct patient group stratification [81]. Here, NEGR1 is linked to depressive symptom measurement.